Skip to main content
Retour
TECX logo

Tectonic Therapeutic, Inc.

Qualité des données : 100%
TECX
NASDAQ Healthcare Biotechnology
29,44 €
▼ 0,44 € (-1,47%)
Cap. Boursière : 552,78M
Fourchette du Jour
29,31 € 30,73 €
Fourchette 52 Semaines
13,70 € 36,03 €
Volume
191 442
Moyenne 50J / 200J
24,16 € / 20,94 €
Clôture Précédente
29,88 €

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Healthcare (626 pairs)

Métrique Action Médiane du Secteur
P/E -7,5 0,4
P/B 2,2 2,9
ROE % -37,8 3,8
Net Margin % 3,9
Rev Growth 5Y % 10,0
D/E 0,0 0,2

Points Clés

Debt/Equity of 0,01 — conservative balance sheet
Negative free cash flow of -60,29M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-37,82%
ROIC-24,95%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
0,01
Current Ratio26,63
Interest Coverage-1333,90

Valorisation

P/E Ratio
-7,45
P/B Ratio2,20
EV/EBITDAN/A
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0,0 Net Income (TTM) -74,15M
ROE -37,82% ROA -28,41%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -60,29M
ROIC -24,95% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,01 Current Ratio 26,63
Interest Coverage -1333,90 Dividend Yield 0,00%
Valuation
P/E Ratio -7,45 P/B Ratio 2,20
P/S Ratio N/A PEG Ratio -1,69
EV/EBITDA N/A Dividend Yield 0,00%
Market Cap 552,78M Enterprise Value 300,26M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0,0 0,0 0,0 0,0 0,0
Net Income -74,15M -57,98M -42,82M -32,18M -8,93M
EPS (Diluted) -4,05 -3,93 -11,53 -29,05 -33,36
Gross Profit 0,0 0,0 0,0 0,0 0,0
Operating Income -84,04M -58,02M -44,65M -32,83M -15,61M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 261,04M 152,91M 39,40M 47,21M 32,88M
Total Liabilities 9,71M 12,13M 124,04M 92,86M 47,84M
Shareholders' Equity 251,33M 140,78M -84,64M -45,65M -14,96M
Total Debt 1,28M 3,30M 4,34M 5,79M 1,06M
Cash & Equivalents 253,80M 141,24M 28,77M 35,97M 28,06M
Current Assets 257,36M 146,86M 30,88M 37,04M 28,62M
Current Liabilities 9,67M 11,61M 40,89M 7,84M 4,12M